Related Experiment Video
Updated: Jul 11, 2025

09:11
Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
Published on: April 9, 2019
21.5K
MR Imaging-Guided Prostate Cancer Therapies
Daniel A Adamo1, Bernadette Marie Greenwood2, Pejman Ghanouni3
1Mayo Clinic, 200 1st Street Southwest, Rochester, MN 55905, USA.
Radiologic Clinics of North America
|November 16, 2023
Summary
Magnetic Resonance (MR) imaging-guided therapies offer alternatives to traditional treatments for localized prostate cancer. Options include cryoablation, laser ablation, and focused ultrasound, though long-term data are still developing.
Area of Science:
- Oncology
- Medical Imaging
- Minimally Invasive Therapies
Background:
- Prostate cancer is the most frequent cancer diagnosed in men.
- Traditional treatments like radical prostatectomy and radiation therapy are standard for prostate cancer.
- MR imaging-guided therapies are emerging as a viable alternative for specific patient groups.
Purpose of the Study:
- To review current MR imaging-guided therapeutic options for prostate cancer.
- To discuss the application of these techniques in localized, low- to intermediate-risk prostate cancer.
- To highlight the growing role of MR imaging in prostate cancer treatment.
Main Methods:
- Literature review of MR imaging-guided prostate cancer therapies.
- Description of techniques including cryoablation, laser ablation, high-intensity focused ultrasound, and transurethral ultrasound ablation.
- Discussion of patient selection criteria for these minimally invasive approaches.
Main Results:
- Several MR imaging-guided therapies are available for prostate cancer treatment.
- These methods are particularly relevant for localized disease with low- to intermediate-risk.
- While promising, long-term oncologic outcome data are still limited for these novel treatments.
Conclusions:
- MR imaging-guided therapies represent an evolving treatment landscape for prostate cancer.
- These techniques offer focal treatment options, potentially reducing side effects compared to whole-gland therapies.
- Further research is needed to establish long-term efficacy and oncologic control.

